Open to closed-loop transition schemes for in vivo glucose control
Continuous Subcutaneous Insulin Infusion (CSII) treatments for peoplewith type 1 diabetes can combine the use of a smart insulin pump with a Continuous GlucoseMonitor (CGM) and a control algorithm to improve the regulation of the insulin delivery. New control algorithms need to be tested in clinical...
Guardado en:
| Autores principales: | , , , |
|---|---|
| Formato: | Objeto de conferencia Resumen |
| Lenguaje: | Inglés |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | http://sedici.unlp.edu.ar/handle/10915/178242 |
| Aporte de: |
| Sumario: | Continuous Subcutaneous Insulin Infusion (CSII) treatments for peoplewith type 1 diabetes can combine the use of a smart insulin pump with a Continuous GlucoseMonitor (CGM) and a control algorithm to improve the regulation of the insulin delivery. New control algorithms need to be tested in clinical trials under strictly safety conditions for the patients. |
|---|